Skip to main content
Clinical Trials/NCT03444896
NCT03444896
Unknown
Not Applicable

The Efficacy and Neural Mechanism of Acupuncture Treatment in Older Adults With Subjective Cognitive Decline: a Randomized Controlled Trial

Beijing Hospital of Traditional Chinese Medicine1 site in 1 country60 target enrollmentApril 25, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Subjective Cognitive Decline
Sponsor
Beijing Hospital of Traditional Chinese Medicine
Enrollment
60
Locations
1
Primary Endpoint
Change in cognitive function
Last Updated
6 years ago

Overview

Brief Summary

This study evaluates the efficacy and mechanism of acupuncture treatment in patients with subjective cognitive decline. Half of patients will receive acupuncture treatment for 12 weeks, while the other half will receive sham acupuncture treatment for 12 weeks .

Registry
clinicaltrials.gov
Start Date
April 25, 2018
End Date
March 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ping Zhou

doctor

Beijing Hospital of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • Male and female adults aged 55-75;
  • Native Chinese speakers with right-handed and at least a primary school education;
  • Self-reported persistent memory decline, which was confirmed by caregivers;
  • Normal general cognitive function and not meeting the criterion of mild cognitive impairment, as defined by performance within the normal range on both measures within at least one cognitive domain or in each of the three cognitive domains sampled (adjusted for age and education);
  • No or minimal impairment in activities of daily living;

Exclusion Criteria

  • Presence of positive neurologic history (e.g., traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis, etc.) ;
  • treatments that would affect cognitive function;
  • Presence of significant psychiatric history (e.g., bipolar disorder, schizophrenia, etc.) and/or severe anxiety and depression;
  • Presence of serious heart, kidney, liver, gastrointestinal, infectious, endocrine disease or cancer;
  • History of alcohol or drug abuse/addiction in nearly two years;
  • Any contraindications for magnetic resonance imaging (MRI) scans (e.g., aneurysm clip pacemaker, etc.);
  • Significant visual and/or auditory impairment uncorrected by aids, and unable to perform neuropsychological evaluations;
  • Currently enrolled in another research study;
  • Received acupuncture treatment in the preceding month.

Outcomes

Primary Outcomes

Change in cognitive function

Time Frame: Changes from baseline at 12 weeks

A composite score will be computed by averaging z-scores from Animal Fluency Test, Digit Symbol Substitution Test, Trail-Making Test Parts A and B, Stroop Color Word Test C, Digit Span Test, Boston Naming Test, Clock Drawing Test and Auditory Verbal Learning Test delayed recall and delayed recognition.

Secondary Outcomes

  • Neuroplasticity outcome(baseline and 12 weeks)

Study Sites (1)

Loading locations...

Similar Trials